CD47 blockade triggers T cell-mediated destruction of immunogenic tumors

Nature Medicine
Xiaojuan LiuMeng Michelle Xu

Abstract

Macrophage phagocytosis of tumor cells mediated by CD47-specific blocking antibodies has been proposed to be the major effector mechanism in xenograft models. Here, using syngeneic immunocompetent mouse tumor models, we reveal that the therapeutic effects of CD47 blockade depend on dendritic cell but not macrophage cross-priming of T cell responses. The therapeutic effects of anti-CD47 antibody therapy were abrogated in T cell-deficient mice. In addition, the antitumor effects of CD47 blockade required expression of the cytosolic DNA sensor STING, but neither MyD88 nor TRIF, in CD11c+ cells, suggesting that cytosolic sensing of DNA from tumor cells is enhanced by anti-CD47 treatment, further bridging the innate and adaptive responses. Notably, the timing of administration of standard chemotherapy markedly impacted the induction of antitumor T cell responses by CD47 blockade. Together, our findings indicate that CD47 blockade drives T cell-mediated elimination of immunogenic tumors.

References

Jun 17, 2000·Science·P A OldenborgF P Lindberg
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·S RoveroG Forni
Apr 3, 2001·The Journal of Experimental Medicine·P A OldenborgF P Lindberg
Apr 18, 2001·Trends in Cell Biology·E J Brown, W A Frazier
Dec 26, 2006·Nature Medicine·Michel ObeidGuido Kroemer
Sep 1, 2007·British Journal of Haematology·Jannie M Rendtlew DanielsenThomas Rasmussen
Nov 6, 2007·Immunological Reviews·Michel ObeidGuido Kroemer
Nov 6, 2007·Nature Immunology·Katsuto TakenakaJayne S Danska
Mar 12, 2008·The Journal of Cell Biology·Richard K Tsai, Dennis E Discher
Mar 15, 2008·Nature Reviews. Immunology·Hajime Kono, Kenneth L Rock
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Keith Syson ChanIrving L Weissman
Jul 27, 2010·Current Opinion in Urology·Keith Syson ChanIrving Weissman
Nov 23, 2010·Nature Reviews. Immunology·Grace Y Chen, Gabriel Nuñez
Dec 24, 2010·Cancer Research·Mark P ChaoRavindra Majeti
Apr 13, 2011·Proceedings of the National Academy of Sciences of the United States of America·John StaggMark J Smyth
Sep 21, 2011·The Journal of Experimental Medicine·Mercedes B FuertesThomas F Gajewski
Sep 21, 2011·The Journal of Experimental Medicine·Mark S DiamondRobert D Schreiber
Dec 14, 2011·Nature Reviews. Cancer·Mark P ChaoIrving L Weissman
Feb 10, 2012·Nature·Hirokazu MatsushitaRobert D Schreiber
Mar 28, 2012·Proceedings of the National Academy of Sciences of the United States of America·Stephen B WillinghamIrving L Weissman
Jun 26, 2012·Nature Reviews. Immunology·Christophe J Desmet, Ken J Ishii
May 18, 2013·Nature Reviews. Immunology·Luke A J O'NeillAndrew G Bowie
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Diane TsengIrving L Weissman
Jun 1, 2013·Science·Kipp WeiskopfK Christopher Garcia
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan

❮ Previous
Next ❯

Citations

Dec 6, 2018·Transfusion·Randall W VelliquetteConnie M Westhoff
Nov 22, 2018·Cancer Science·Ashanti Concepción Uscanga-PalomequeCristina Rodríguez-Padilla
Jan 31, 2019·The New England Journal of Medicine·Ranjana AdvaniMark P Chao
Oct 5, 2018·Annual Review of Animal Biosciences·Janos ZempleniEzra Mutai
Oct 9, 2015·Nature Medicine·Robert H Vonderheide
Nov 26, 2015·Nature Reviews. Clinical Oncology·Mark J SmythMichele W L Teng
Mar 11, 2016·Cell Death & Disease·H ZhouG Kroemer
Sep 21, 2016·Nature Immunology·Qi ChenZhijian J Chen
Nov 7, 2019·Expert Review of Anticancer Therapy·Emmanouil TzatzarakisSebastian Schölch
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Gregory L Beatty
Sep 6, 2019·Cellular Oncology (Dordrecht)·Seyed Mohammad Gheibi HayatAmirhossein Sahebkar
Jan 7, 2020·Nanoscale·Anujan RameshAshish Kulkarni
Mar 7, 2020·The Journal of Experimental Medicine·Yaoyao ShiYang-Xin Fu
Feb 14, 2020·Science Translational Medicine·Candice R GurbatriTal Danino
Feb 7, 2020·The Journal of Clinical Investigation·Jing LiWeiping Zou
Oct 14, 2017·Immunological Reviews·Thaiz Rivera Vargas, Lionel Apetoh
Jun 5, 2020·The Journal of Experimental Medicine·Shih-Ying WuKounosuke Watabe
Aug 11, 2020·Oncotarget·Brandon Yi Da HoongEe Sin Chen
Aug 30, 2019·Nature Reviews. Cancer·Mingye FengIrving L Weissman
Aug 16, 2019·Physiological Reviews·Carla Riera-DomingoMassimiliano Mazzone
Aug 5, 2020·Journal of Hematology & Oncology·Yingying WangHong-Wu Xin
Apr 29, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Pradeep ShresthaHaval Shirwan
Sep 29, 2020·Expert Opinion on Biological Therapy·Victor I Seledtsov, Alexei von Delwig

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
xenograft
FCS

Software Mentioned

GraphPad
Prism

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.